Illumina et al. in €16m series-A for Stilla Technologies

Kurma Partners, LBO France, BNP Paribas Developpement, Paris Saclay Seeds and Idinvest Partners also took part in the round.

The new funding will enable Stilla to invest in the marketing of its Naica System, launch its second generation product and introduce clinical validation panels to be run on the system, with an initial focus in the field of oncology.

Illumina's Nick Naclerio, Kurma's Philippe Peltier and LBO France's Philippe Chambon have joined the board of directors as part of the deal, replacing the seed investors.

The transaction comes two months after London Stock Exchange-listed Photo-Me, an instant-service equipment group, announced that it had completed the sale of its 50% stake in Stilla Technologies.

Company
Founded 2016, Paris-based Stilla develops equipment that enables scientists to detect and quantify DNA mutations. The startup serves research organisations specialising in molecular biology and genetic analysis.

People
Stilla Technologies – Remi Dangla (CEO, co-founder).
Illumina Ventures – Nick Naclerio (founding partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• France
• Healthcare
• France
• LBO France
• BNP Paribas Développement
• IDInvest Partners (AGF Private Equity)